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A swelling of the lateral hard palate  
 
The Challenge 
A 17-year-old male was referred by his general dentist to an oral and 
maxillofacial surgeon in private practice in Montreal QC for biopsy and further 
treatment of a painless swelling of the hard palate (Fig. 1). The patient had not 
noticed the lesion and was unaware of its duration. 
The initial review of the medical history did not provide any relevant information 
and the patient did not report any particular health problems. No significant 
abnormalities were visible on extraoral examination of the head, neck and visible 
skin. 
The intraoral examination showed a firm swelling on the right side of the hard 
palate, measuring approximately 20 mm x 30 mm x 10 mm. The overlying 
mucosa appeared normal. The adjacent teeth were not displaced or mobile. 
Vitality testing demonstrated that all teeth from the left lateral incisor to the first 
molar were vital. Radiologic studies, including a panoramic radiograph and CBCT 
scan, revealed no intrabony lesion or superficial cortical erosion. An incisional 
biopsy of the mass was performed.  
Histopathological evaluation revealed a non-encapsulated proliferation of 
spindle-shaped cells with wavy nuclei in a dense fibrous stroma. In other regions, 
the stroma was looser and less collagenized (Fig. 2). The lesional cells at the 
3	
	
periphery of the tumor blended with adjacent normal tissue. Many mast cells 
were observed between the spindle cells (Fig. 3 A). Dilated blood vessels and 
numerous nerve fibres of different calibers were present in the center of the 
lesion. The lesion was surfaced by unremarkable parakeratinized stratified 
squamous epithelium. Immunohistochemical studies showed a scattered positive 
reaction for S-100 protein within the lesional spindle cells (Fig. 3 B).  
 
Differential Diagnosis 
1. Pleomorphic adenoma 
2. Mucoepidermoid carcinoma 
3. Polymorphous low-grade adenocarcinoma 




The histopathological examination confirmed the diagnosis of neurofibroma. The 
S-100 protein immunohistochemical stain mentioned in the diagnostic work-up 
for this case is a common marker used by pathologists to identify lesions of 
neural or melanocytic origin. Neurofibromas are benign peripheral nerve sheath 
tumors that may occur as solitary lesions or multiple lesions associated with a 
hereditary condition called neurofibromatosis type 1 (NF1, or von 
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Recklinghausen’s disease of the skin). In the general population, neurofibromas 
are most commonly cutaneous tumors, but they are not rare in the oral cavity. 
Intraoral neurofibromas most commonly occur on the tongue and buccal mucosa. 
They are more frequent in patients with NF1.1-3 They arise as a slow-growing, 
sessile, mobile and usually painless lesion that can vary in size from a small 
nodule to a large swelling.4 
Following the diagnosis of a neurofibroma, the possibility of neurofibromatosis 
must be considered. The patient should be investigated for this condition, 
especially if they present with additional signs of the disease. The diagnostic 
criteria for NF1 were established at the National Institutes of Health Development 
Conference held in 1987, and are presented in Table 1. NF1 is an inherited 
autosomal dominant disorder affecting about 1 in 3000 individuals.5 Although 
many cases are hereditary, 50% of patients have no family history and present 
as spontaneous mutations.6 
During further clinical evaluation, the patient actually met the diagnostic criteria 
for NF1. He presented with six or more café au lait macules on his chest, arms 
and back (Fig. 4 A). He subsequently admitted to having multiple neurofibromas 
throughout his life. In addition to the palatal neurofibroma, another neurofibroma 
was actually present on his lower back (Fig. 4 B). He also demonstrated axillary 
freckling (Fig. 4 C). When questioned on his family history, he revealed that one 
of his parents was affected by NF1.  
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The treatment recommended for neurofibromas of the oral cavity is a complete 
surgical excision of the lesion, which was performed. Recurrence is rare. There 
was no recurrence 2 years following treatment.  
Malignant transformation is rare in small, solitary neurofibromas. However, for 
patients with NF1, the lifetime risk of developing a malignant peripheral nerve 
sheath tumor (MPNST) is 8-13%.7 Most MPNSTs develop in pre-existing 
plexiform neurofibromas, which, compared to solitary neurofibromas, present as 
larger, pendulous or diffuse tumors.  The prognosis of these malignant tumors 
associated with NF1 is poor: the five-year survival rate is of 21%.7 Compared to 
the general population, patients with NF1 have a reduced average lifespan by 
10-15 years, mostly related to malignant tumors and the development of 
hypertension.6,7 Systematic, long-term medical follow-up and genetic counseling 
are important aspects in the management of patients with neurofibromatosis. 
 
Differential Diagnosis 
The clinical differential diagnosis for this swelling of the hard palate included 
salivary gland tumors (pleomorphic adenoma, mucoepidermoid carcinoma and 
polymorphous low grade adenocarcinoma) as well as neurofibroma and Non-
Hodgkin lymphoma.  
Pleomorphic adenoma. Pleomorphic adenoma, also called benign mixed tumor, 
is the most common salivary gland neoplasm in both major and minor glands. 
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Pleomorphic adenomas are derived from epithelial and myoepithelial elements 
with a highly variable pattern among different tumors. The palate is the most 
common site when it occurs in minor glands. The tumor appears as a painless, 
slowly growing, firm swelling. It can occur at any age, but mostly between the 4th 
and 7th decades of life with a female predilection.8-10  
Mucoepidermoid carcinoma. Mucoepidermoid carcinoma (MEC) is the most 
common malignant salivary tumor. MEC is composed of mucus-producing cells, 
epidermoid and intermediate cells. This tumor most commonly arises in the 
parotid gland, appearing as an asymptomatic slowly growing mass. Intraorally, 
the palate constitutes the most common site when minor salivary glands are 
affected. Intraoral MEC also manifests as an asymptomatic swelling, which often 
has a bluish colour due to its mucus content. MEC can occur from the 2nd to the 
7th decades of life. Although this tumor is uncommon in the 1st decade of life, it is 
the main malignant salivary gland neoplasm in children.10-12 
Polymorphous low-grade adenocarcinoma. Polymorphous low-grade 
adenocarcinoma (PLGA) is one of the most common malignancies affecting 
minor salivary glands. It occurs almost exclusively in minor salivary glands, 
especially on the hard or soft palate. PLGA usually appears as a painless slowly 
growing mass. This tumor is characterized by its infiltrating character. It is known 
to invade the underlying palatal bone and has a tendency to show perineural 
invasion. Regional metastases to the cervical lymph nodes is relatively 
infrequent, occurring in up to 17% of patients.10 Distant metastasis is rare. PLGA 
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is usually seen in older adults, between the 6th and 8th decades of life, but the 
tumor may affect patients of all ages. There is a female predilection.10,13,14 
Non-Hodgkin Lymphoma. Lymphomas are malignant neoplasms of lymphoid 
tissue. They originate from precursor cells of the B-lymphocyte or T-lymphocyte 
series. Lymphomas are broadly classified as Hodgkin lymphoma (HL) and non-
Hodgkin lymphoma. Non-Hodgkin lymphomas (NHL) are by far the most 
common. Further discussion will be focused on NHL, as intraoral presentation of 
HL is quite rare. NHL mostly develop in lymph nodes, but extranodal lymphomas 
can present in the oral cavity. They can develop in the oral soft tissues or 
centrally within the jaw bones. Soft tissue lesions appear as boggy and diffuse 
swellings affecting the posterior hard palate, buccal vestibule, or gingiva. The 
lesion may be erythematous and sometimes ulcerated. NHL occurs mostly in 
adults, but children may also be affected. Diffuse large B cell lymphoma is the 
most frequent NHL presenting in the oral cavity.15,16 
 
Conclusion 
Although neurofibromas are relatively infrequent tumors in the oral cavity, this 
case shows that it should be included in the differential diagnosis of a palatal 
mass.  A diagnosis of solitary oral neurofibroma should prompt the clinician to 
further evaluate the patient for NF1, because the oral lesion could be the first 
manifestation of the systemic condition. In this case, although the patient 
presented to his dentist with what seemed to be an isolated palatal neurofibroma, 
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the final diagnosis was NF1. The collection of signs of the syndrome were not 
readily apparent and only discovered after careful questioning and clinical 
examination. Since a small proportion of patients with NF1 will go on to develop 
MPNSTs or cardiovascular disease with a poor prognosis, early recognition of 
this condition, genetic counseling and long-term medical monitoring are 
important. This case demonstrates the important role dentists can play in 












Figure 2. Low-power view showing a non-encapsulated cellular proliferation 
within the lamina propria. (Original magnification 4x, H&E).  
	
Figure 3. A. High-power view showing spindle-shaped cells with wavy nuclei 
(arrows) intermingled with multiple mast cells (circles). (Original magnification 
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40x, H&E). B. Medium-power photomicrograph showing scattered S-100 protein 
immunoreactivity. (Original magnification 10x). 
	
	
Figure 4. A. Front view showing several café au lait macules on the patient's 
chest and arms. B. Dorsal view showing other café au lait macules and a 
neurofibroma on the patient’s lower back (magnified inset). C. Axillary freckling. 
 
 
The diagnostic criteria for NF1 are met if a patient has two or more of the following features: 
1. Six or more café au lait macules  
- More than 5 mm in diameter in prepubertal persons 
- More than 15 mm in diameter in postpubertal persons 
2. Two or more neurofibromas of any type or one plexiform neurofibroma 
3. Freckling in the axillary or inguinal region 
4. Optic glioma 
5. Two or more Lisch nodules (iris hamartomas) 
6. A distinctive osseous lesion (such as sphenoid dysplasia or thinning of long bone 
cortex, with or without pseudoarthrosis) 
7. A first degree relative with NF1 (according to the previously mentioned criteria)  
 
Table 1. National Institutes of Health Diagnostic Criteria for Neurofibromatosis 
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